Consumer Staples [ 8/12 ] | Personal Care Products [ 54/74 ]
NASDAQ | Common Stock
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products.
It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name.
It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines.
The company is headquartered in Lehi, Utah.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 29, 24 | 0.15 Increased by +15.38% | 0.15 |
| Aug 28, 24 | 0.14 Decreased by -17.65% | 0.21 Decreased by -33.33% |
| May 2, 24 | 0.21 Increased by +162.50% | 0.16 Increased by +31.25% |
| Jan 30, 24 | 0.10 Increased by +242.86% | 0.04 Increased by +150.00% |
| Nov 9, 23 | 0.13 Increased by +116.67% | 0.15 Decreased by -13.33% |
| Aug 28, 23 | 0.17 Increased by +1.60 K% | 0.20 Decreased by -15.00% |
| May 4, 23 | 0.08 Decreased by -33.33% | 0.15 Decreased by -46.67% |
| Feb 2, 23 | -0.07 Decreased by -240.00% | 0.05 Decreased by -240.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 47.21 M Decreased by -8.08% | 1.83 M Increased by +190.30% | Increased by +3.87% Increased by +215.82% |
| Jun 30, 24 | 48.93 M Decreased by -9.76% | 1.30 M Decreased by -33.62% | Increased by +2.67% Decreased by -26.45% |
| Mar 31, 24 | 48.24 M Decreased by -10.23% | 1.66 M Increased by +62.33% | Increased by +3.44% Increased by +80.82% |
| Dec 31, 23 | 51.62 M Decreased by -3.80% | -656.00 K Increased by +38.00% | Decreased by -1.27% Increased by +35.55% |
| Sep 30, 23 | 51.36 M Decreased by -0.79% | 629.00 K Increased by +3.11% | Increased by +1.22% Increased by +3.94% |
| Jun 30, 23 | 54.22 M Increased by +6.43% | 1.97 M Increased by +238.84% | Increased by +3.63% Increased by +230.45% |
| Mar 31, 23 | 53.74 M Increased by +7.47% | 1.02 M Decreased by -10.43% | Increased by +1.90% Decreased by -16.66% |
| Dec 31, 22 | 53.66 M Increased by +2.82% | -1.06 M Decreased by -1.44 K% | Decreased by -1.97% Decreased by -1.40 K% |